Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in ADIL — Adial Pharmaceuticals, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to ADIL Full portfolio

Position in ADIL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$15
+$5 QoQ
Shares Held
6
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 17 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADIL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. ADIL ranks #404 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in ADIL

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15 6
2026-03-31 $10 6
2025-12-31 $35 160
2025-09-30 $56 160
2025-06-30 $48 160
2025-03-31 $100 160
2024-12-31 $161 160
2024-03-31 $14 11
2023-12-31 $14 8
2023-09-30 $22 8
2023-06-30 $39 187
2023-03-31 $321 919
2022-12-31 $201 916
2022-09-30 $351 1,005
2022-06-30 $1,334 996
2022-03-31 $1,945 968
2021-12-31 $2,335 865
2021-09-30 $3,710 865
2021-06-30 $2,098 823
2021-03-31 $1,955 808
2020-12-31 $1,368 805
2020-09-30 $1,781 799
2020-06-30 $1,098 791
2020-03-31 $1,028 791